Current Opinion in Hematology was launched in 1994. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of hematology is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Dr Bacigalupo is the Head of the Division of Hematology and Stem Cell Transplants at Ospedale San Martino, Genova, Italy. He graduated in 1973 from the Genova Medical School, Italy, and started an allogeneic transplant program in 1976. He has conducted several clinical trials in patients with aplastic anemia and in patients undergoing allogeneic transplants. His main interests are bone marrow failure, Graft-versus-Host-Disease (GvHD) and related complications, and graft versus leukemia reactions. He has also been interested in cytomegalovirus and Epstein–Barr virus infections, looking at early diagnosis and prospective studies on prophylaxis and pre-emptive therapy. Dr Bacigalupo has served as a board member of the European Group for Bone Marrow Transplantation (EBMT) for several years, as secretary, then Chairperson of the Aplastic Anemia Working Party and then as President from 1998 to 2002. He served as President of the Italian Group of Bone Marrow Transplantation (GITMO) from 2002 to 2005. He has been a member of the Italian National Health Council for two terms (2000–2006). He has served on the Regimen Related Toxicity Working Group of the Center for International Blood and Marrow Transplant Research (CIBMTR).
Dr Bacigalupo has published over 500 articles in peer-reviewed journals and he is a member of several national and international hematology societies. He is Associate Editor of the journal Bone Marrow Transplantation and Biology of Blood and Marrow Transplantation. He serves on the Board of Haematologica and of the Journal of Clinical Oncology.
Jed B. Gorlin
Dr Jed B. Gorlin is board certified in pediatrics and blood banking and transfusion medicine. Dr Gorlin is the Vice President of Medical and Quality Affairs for Innovative Blood Resources, USA. He received his undergraduate degree from Stanford University, USA, a MD degree from Yale University, USA, and a MBA from the University of Minnesota's Carlson School of Business, USA.
Dr Gorlin trained in pediatrics and pediatric hematology/oncology at Boston Children's hospital, USA, and completed research fellowships at Dana-Farber Cancer Institute, USA, Massachusetts General Hospital, USA, Brigham & Women's Hospital, USA, and the Puget Sound Blood Center, USA.
Dr Gorlin served on the boards of AABB and the National Blood Foundation. He is currently the Co-Director of Transfusion Medicine at Hennepin County Medical Center, a level one trauma hospital in Minneapolis, USA, and the Children's Hospitals and Clinics in Minneapolis and St. Paul, USA. He is a consultant to AABB and CDC for projects in Rwanda, Tanzania and Central Asia including Kazakhstan and Kyrgyzstan.